154 related articles for article (PubMed ID: 2167150)
1. Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center.
Mutch DG; Soper JT; Babcock CJ; Clarke-Pearson DL; Hammond CB
Cancer; 1990 Sep; 66(5):978-82. PubMed ID: 2167150
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic trophoblastic disease with poor prognosis.
Surwit EA; Hammond CB
Obstet Gynecol; 1980 May; 55(5):565-70. PubMed ID: 6245395
[TBL] [Abstract][Full Text] [Related]
3. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
Soper JT; Clarke-Pearson D; Hammond CB
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
[TBL] [Abstract][Full Text] [Related]
4. Gestational trophoblastic disease metastatic to the central nervous system.
Evans AC; Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez GC; Hammond CB
Gynecol Oncol; 1995 Nov; 59(2):226-30. PubMed ID: 7590478
[TBL] [Abstract][Full Text] [Related]
5. Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours.
Froeling FEM; Ramaswami R; Papanastasopoulos P; Kaur B; Sebire NJ; Short D; Fisher RA; Sarwar N; Wells M; Singh K; Ellis L; Horsman JM; Winter MC; Tidy J; Hancock BW; Seckl MJ
Br J Cancer; 2019 Mar; 120(6):587-594. PubMed ID: 30792530
[TBL] [Abstract][Full Text] [Related]
6. Late recurrence of gestational trophoblastic disease.
Jones WB; Lewis JL
Gynecol Oncol; 1985 Jan; 20(1):83-91. PubMed ID: 2981192
[TBL] [Abstract][Full Text] [Related]
7. Utility of assay of alpha subunit of human chorionic gonadotropin in management of gestational, trophoblastic malignancies.
Quigley MM; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1980 Nov; 138(5):545-9. PubMed ID: 6158863
[TBL] [Abstract][Full Text] [Related]
8. Intensive inpatient therapy and survival in gestational trophoblastic disease.
Weed JC; Jelovsek FR; Tyrey L; Hammond CB
Gynecol Oncol; 1983 Jun; 15(3):363-9. PubMed ID: 6305783
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and therapeutic curettage in gestational trophoblastic disease.
Schlaerth JB; Morrow CP; Rodriguez M
Am J Obstet Gynecol; 1990 Jun; 162(6):1465-70; discussion 1470-1. PubMed ID: 2163193
[TBL] [Abstract][Full Text] [Related]
10. Salvage surgery for chemorefractory gestational trophoblastic disease.
Lehman E; Gershenson DM; Burke TW; Levenback C; Silva EG; Morris M
J Clin Oncol; 1994 Dec; 12(12):2737-42. PubMed ID: 7989951
[TBL] [Abstract][Full Text] [Related]
11. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center.
Finkler NJ; Berkowitz RS; Driscoll SG; Goldstein DP; Bernstein MR
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):854-7. PubMed ID: 2835717
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognostic factors and staging in gestational trophoblastic tumor.
Soper JT; Evans AC; Conaway MR; Clarke-Pearson DL; Berchuck A; Hammond CB
Obstet Gynecol; 1994 Dec; 84(6):969-73. PubMed ID: 7970479
[TBL] [Abstract][Full Text] [Related]
14. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
15. Surgical therapy for gestational trophoblastic disease.
Soper JT
J Reprod Med; 1994 Mar; 39(3):168-74. PubMed ID: 8035372
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of metastatic trophoblastic disease after negative, plasma human chorionic gonadotropin beta-subunit assay.
McComb P; Ho Yuen B; Boyes D; White G
Gynecol Oncol; 1980 Feb; 9(1):114-6. PubMed ID: 6243596
[No Abstract] [Full Text] [Related]
17. [Factors related to recurrence of choriocarcinoma and evaluation of treatment outcomes].
Sun Y; Xiang Y; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):329-32. PubMed ID: 16762190
[TBL] [Abstract][Full Text] [Related]
18. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
Sasaki S; Sasaki Y; Iino K
J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
[TBL] [Abstract][Full Text] [Related]
19. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
20. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
